Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis
  2. Matthews, C. P.; Birkholz, A. M.; Baker, A. R.; Perella, C. M.; Becky, G. R.; Young, M. R.; Colburn, N. H.
  3. Cancer Research. 2007, Mar; 67(6): 2430-2438.
  1. 2.   Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure
  2. Liu, J.; Xie, Y. X.; Ducharme, D. M. K.; Shen, J.; Diwan, B. A.; Merrick, B. A.; Grissom, S. F.; Tucker, C. J.; Paules, R. S.; Tennant, R.; Waalkes, M. P.
  3. Environmental Health Perspectives. 2006, MAR; 114(3): 404-411.
  1. 3.   Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide
  2. Chen, K. Q.; Iribarren, P.; Hu, J. Y.; Chen, J. H.; Gong, W. H.; Cho, E. H.; Lockett, S.; Dunlop, N. M.; Wang, J. M.
  3. Journal of Biological Chemistry. 2006, FEB 10; 281(6): 3651-3659.
  1. 4.   FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis
  2. Li, C. L.; Xu, X. L.; Nelson, D. K.; Williams, T.; Kuehn, M. R.; Deng, C. X.
  3. Development. 2005, NOV; 132(21): 4755-4764.
  1. 5.   Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype
  2. Kowara, R.; Karaczyn, A.; Cheng, R. Y. S.; Salnikow, K.; Kasprzak, K. S.
  3. Toxicology and Applied Pharmacology. 2005, MAY 15; 205(1): 1-10.
  1. 6.   Nitric oxide, a mediator of inflammation, suppresses tumorigenesis
  2. Hussain, S. P.; Trivers, G. E.; Hofseth, L. J.; He, P. J.; Shaikh, I.; Mechanic, L. E.; Doja, S.; Jiang, W. D.; Subleski, J.; Shorts, L.; Haines, D.; Laubach, V. E.; Wiltrout, R. H.; Djurickovic, D.; Harris, C. C.
  3. Cancer Research. 2004, OCT 1; 64(19): 6849-6853.
  1. 7.   Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic
  2. Liu, J.; Xie, Y. X.; Ward, J. M.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicological Sciences. 2004 77(2): 249-257.
  1. 8.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 9.   Role of Ets/Id proteins for telomerase regulation in human cancer cells
  2. Xiao, X. D.; Athanasiou, M.; Sidorov, I. A.; Horikawa, I.; Cremona, G.; Blair, D.; Barret, J. C.; Dimitrova, D. S.
  3. Experimental and Molecular Pathology. 2003 75(3): 238-247.
  1. 10.   ERF, an ETS-related transcriptional repressor, can induce erythroid differentiation
  2. Athanasiou, M.; Blair, D. G.; Mavrothalassitis, G.
  3. Anticancer Research. 2003, MAY-JUNE; 23(3A): 2143-2153.
  1. 11.   A potential mechanism for fumonisin B-1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3 beta activity
  2. Ramljak, D.; Calvert, R. J.; Wiesenfeld, P. W.; Diwan, B. A.; Catipovic, B.; Marasas, W. F. O.; Victor, T. C.; Anderson, L. M.; Gelderblom, W. C. A.
  3. Carcinogenesis. 2000 21(8): 1537-1546.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel